awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33916749-6FB7C2DA-DA51-4DAD-B99C-FAB615126852
Q33916749-6FB7C2DA-DA51-4DAD-B99C-FAB615126852
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33916749-6FB7C2DA-DA51-4DAD-B99C-FAB615126852
Drug candidates in clinical trials for Alzheimer's disease.
P2860
Q33916749-6FB7C2DA-DA51-4DAD-B99C-FAB615126852
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33916749-6FB7C2DA-DA51-4DAD-B99C-FAB615126852
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2cbe3da6330b0fcd2e7349b4e7b65f57ee4de21a
P2860
The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer's disease patients.